Skip to content
Subscriber Only

Double-Chin Drug From Kythera Wins U.S. FDA Approval

Updated on

Kythera Biopharmaceuticals Inc. won approval for a first-of-its-kind double-chin treatment.

The drug, called Kybella, is injected into the fat below the chin and destroys the fat cells, the Food and Drug Administration said in a statement. The agency warned that Kybella can also kill skin cells if inadvertently injected into the skin.